Awards & Honors

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2004

2001

MicroPort® was awarded "2018 Responsible Brand" at the 8th China Charity Festival.

The Group’s Firehawk® and Rega® Family Implantable Pacemakers made the list of Health China (2018) • Top 10 Medical Devices.

The Group’s Panoramic Endoscope Design won iF DESIGN AWARD 2019.

The Group won Shanghai Municipality Gold Quality Prize.

The Group won the title of 2018 Shanghai Municipality Quality Benchmark Enterprise.

The Group was one of the first winners of Shanghai Brand certificate.

The Group’s “微创®” and “MicroPort®” trademarks were granted entry into the List of the First Batch of Major Protected Trademarks of Shanghai Municipality.

MicroPort® was awarded Five Star Credit Enterprise.

MicroPort® was awarded Corporate Social Responsibility Award of Shanghai Pudong District.

The Group’s project of Development and Large-scale Industrialization of Key Technologies for Aortic Stent Graft Series Products won the Second Prize of the National Science and Technology Progress Awards.

The Group was awarded the title of China Import & Export Quality Trustworthy Enterprise in 2017.

The Group awarded the title of China Innovation Medical Device Enterprise in 2017.

The Group was a holder of the Shanghai Famous Brand title for 12 consecutive years.

The Group was awarded the title of Shanghai Municipality Excellent Innovation Pilot Enterprise in 2017.

The Group was awarded the title of Pudong New Area International Trade Brand Model Enterprise.

"New Technology and Clinical Application of Minimally Invasive Cardiac Surgery" Project Won the Second Prize of State Science and Technology Progress Award.

MicroPort® was listed among "2016 National Technology Innovation Model Enterprises."

MicroPort® was awarded Five Star Credit Enterprise.

MicroPort® was granted the Annual PMO (Project Management Office) Award and Project Management Award Finalist by PMI (Project Management Institute).

"Key technology and industrialization platform for minimally invasive interventional and implantable medical devices" project won prestigious class II prize of State Science and Technology Advancement Award.

Shanghai MicroPort EP MedTech Co., Ltd. received "Shanghai Hi-Tech Enterprise" honor.

WILLIS® clinical application project won prestigious class II prize of State Science and Technology Advancement award.

WILLIS® intracranial stent graft system received 2013 Shanghai new product patent certificate.

"微创®" and "MicroPort®" trademarks received "China Famous Trademark" honor.

Four projects were listed in Shanghai Science and Technology Committee's science and technology support program.

WILLIS® clinical application project won Ministry of Education's Science and Technology Progress Award.

"R&D of Domestic implantable dual chamber pacemaker system" was selected for Shanghai Science and Technology Committee’s science and technology support program.

"Drug eluting stent" patent won 14th "China Patent Excellence Award".

Received "Top Ten Business Award" from Shanghai Biopharmaceutics Industry Association.

2012 national enterprise technology center's innovation capacity building project was officially approved.

"Cerebral vascular interventional medical device development and clinical research" project was selected for "12th Five year plan" of national science and technology support program.

APOLLO was selected as a national key new product project.

Received China Torch Program's key high-tech enterprise certification.

"R&D and industrialization of chronic disease treatment devices" was listed as a Shanghai bio-pharmaceutics industrialization projects.

Received national enterprise technology center certification.

Drug eluting stent system received innovation product certificate from Ministry of Science and Technology.

Awarded title of "Shanghai technology small giant enterprise" by two Shanghai municipal government agencies.

Firebird2™ was awarded Shanghai key new product certificate by Shanghai Science and Technology Committee.

"Drug eluting stent" was awarded class II prize of State Science and Technology Advancement award.

Coronary stent system was selected as a national key new product project.

Awarded title of "high-tech enterprise" by certifications from four Shanghai municipal government agencies.